Woodrow Adam 4
4 · Paratek Pharmaceuticals, Inc. · Filed Oct 27, 2022
Insider Transaction Report
Form 4
Woodrow Adam
VP & Chief Commercial Officer
Transactions
- Award
Common Stock
2022-10-25+15,000→ 650,170 total
Footnotes (1)
- [F1]Represents performance-based restricted stock units granted on July 31, 2019 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on October 25, 2022.